581 related articles for article (PubMed ID: 26437603)
1. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
Grabner A; Amaral AP; Schramm K; Singh S; Sloan A; Yanucil C; Li J; Shehadeh LA; Hare JM; David V; Martin A; Fornoni A; Di Marco GS; Kentrup D; Reuter S; Mayer AB; Pavenstädt H; Stypmann J; Kuhn C; Hille S; Frey N; Leifheit-Nestler M; Richter B; Haffner D; Abraham R; Bange J; Sperl B; Ullrich A; Brand M; Wolf M; Faul C
Cell Metab; 2015 Dec; 22(6):1020-32. PubMed ID: 26437603
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
[TBL] [Abstract][Full Text] [Related]
3. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
Grabner A; Schramm K; Silswal N; Hendrix M; Yanucil C; Czaya B; Singh S; Wolf M; Hermann S; Stypmann J; Di Marco GS; Brand M; Wacker MJ; Faul C
Sci Rep; 2017 May; 7(1):1993. PubMed ID: 28512310
[TBL] [Abstract][Full Text] [Related]
4. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
[TBL] [Abstract][Full Text] [Related]
5. FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice.
Han X; Cai C; Xiao Z; Quarles LD
J Mol Cell Cardiol; 2020 Jan; 138():66-74. PubMed ID: 31758962
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
Singh S; Grabner A; Yanucil C; Schramm K; Czaya B; Krick S; Czaja MJ; Bartz R; Abraham R; Di Marco GS; Brand M; Wolf M; Faul C
Kidney Int; 2016 Nov; 90(5):985-996. PubMed ID: 27457912
[TBL] [Abstract][Full Text] [Related]
7. FGF23 induces left ventricular hypertrophy.
Faul C; Amaral AP; Oskouei B; Hu MC; Sloan A; Isakova T; Gutiérrez OM; Aguillon-Prada R; Lincoln J; Hare JM; Mundel P; Morales A; Scialla J; Fischer M; Soliman EZ; Chen J; Go AS; Rosas SE; Nessel L; Townsend RR; Feldman HI; St John Sutton M; Ojo A; Gadegbeku C; Di Marco GS; Reuter S; Kentrup D; Tiemann K; Brand M; Hill JA; Moe OW; Kuro-O M; Kusek JW; Keane MG; Wolf M
J Clin Invest; 2011 Nov; 121(11):4393-408. PubMed ID: 21985788
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.
Graves JM; Vallejo JA; Hamill CS; Wang D; Ahuja R; Patel S; Faul C; Wacker MJ
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2283-H2294. PubMed ID: 33929896
[TBL] [Abstract][Full Text] [Related]
9. FGFR4 does not contribute to progression of chronic kidney disease.
Taylor A; Yanucil C; Musgrove J; Shi M; Ide S; Souma T; Faul C; Wolf M; Grabner A
Sci Rep; 2019 Oct; 9(1):14023. PubMed ID: 31575945
[TBL] [Abstract][Full Text] [Related]
10. S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice.
Yuan YP; Shen ZY; Teng T; Xu SC; Kong CY; Zeng XF; A Hofmann Bowman M; Yan L
J Am Heart Assoc; 2024 May; 13(10):e028006. PubMed ID: 38726894
[TBL] [Abstract][Full Text] [Related]
11. FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis.
Böckmann I; Lischka J; Richter B; Deppe J; Rahn A; Fischer DC; Heineke J; Haffner D; Leifheit-Nestler M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540546
[TBL] [Abstract][Full Text] [Related]
12. Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease.
Watanabe K; Fujii H; Okamoto K; Kono K; Goto S; Nishi S
Front Endocrinol (Lausanne); 2023; 14():1276664. PubMed ID: 38174329
[TBL] [Abstract][Full Text] [Related]
13. Genetic background influences cardiac phenotype in murine chronic kidney disease.
Neuburg S; Dussold C; Gerber C; Wang X; Francis C; Qi L; David V; Wolf M; Martin A
Nephrol Dial Transplant; 2018 Jul; 33(7):1129-1137. PubMed ID: 29309658
[TBL] [Abstract][Full Text] [Related]
14. FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-β autoinduction.
Smith ER; Holt SG; Hewitson TD
Int J Biochem Cell Biol; 2017 Nov; 92():63-78. PubMed ID: 28919046
[TBL] [Abstract][Full Text] [Related]
15. Hypericin alleviates Chronic Kidney Disease induced Left Ventricular Hypertrophy via regulation of FGF23-FGFR4 signaling pathway.
Liu M; Cheng L; Ye Q; Liu H; Shu C; Gao H; Liu X; Zhang X; Chen G
J Cardiovasc Pharmacol; 2024 Mar; ():. PubMed ID: 38547517
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect effects of fibroblast growth factor 23 on the heart.
Nakano T; Kishimoto H; Tokumoto M
Front Endocrinol (Lausanne); 2023; 14():1059179. PubMed ID: 36909314
[TBL] [Abstract][Full Text] [Related]
17. Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.
Liu ES; Thoonen R; Petit E; Yu B; Buys ES; Scherrer-Crosbie M; Demay MB
Endocrinology; 2018 May; 159(5):2165-2172. PubMed ID: 29635291
[TBL] [Abstract][Full Text] [Related]
18. Cardiac actions of fibroblast growth factor 23.
Faul C
Bone; 2017 Jul; 100():69-79. PubMed ID: 27725315
[TBL] [Abstract][Full Text] [Related]
19. Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23.
Matsui I; Oka T; Kusunoki Y; Mori D; Hashimoto N; Matsumoto A; Shimada K; Yamaguchi S; Kubota K; Yonemoto S; Higo T; Sakaguchi Y; Takabatake Y; Hamano T; Isaka Y
Kidney Int; 2018 Jul; 94(1):60-71. PubMed ID: 29751971
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-30 regulates left ventricular hypertrophy in chronic kidney disease.
Bao J; Lu Y; She Q; Dou W; Tang R; Xu X; Zhang M; Zhu L; Zhou Q; Li H; Zhou G; Yang Z; Shi S; Liu Z; Zheng C
JCI Insight; 2021 May; 6(10):. PubMed ID: 33848263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
